---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-050889"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T00:50:50.202865+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms FY 2025 adjusted EPS guidance of $34.15-$34.85

## Summary
- Reaffirms 2025 shareholders' earnings per diluted share of $30.40-$31.10, including ~$3.75 net unfavorable items.
- Adjusted shareholders' earnings guidance unchanged at $34.15-$34.85 per diluted share.
- Expects 2025 year-end total medical enrollment consistent with prior guidance; Medicare Advantage members 2.2-2.25 million.
- Management to reiterate these projections in investor meetings over coming weeks.

## SEC filing metadata
- accession: 0001193125-25-050889
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312525050889/0001193125-25-050889-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312525050889/d926071d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-050889
- JSON: https://secwatch.observer/filing/0001193125-25-050889.json
- Plain text: https://secwatch.observer/filing/0001193125-25-050889.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.